EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Development and evaluation of Newcastle disease - avian influenza bivalent vector vaccines in commercial chickens

Qing Wu, Lan Wei, Xin Du, Wenying Sun, Shuang Li, Xiaochen Guo, Ming Jiang, Jinmiao Liu, Zhiqiang Xue, Huijuan Li, Tingting Zhang, Wei Wang und 1 weitere

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110363 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Qing Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, China. Hauptthemen laut MEDLINE: Newcastle Disease, Viral Vaccines, Influenza in Birds, Poultry Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Institutes of Health, National Natural Science Foundation of China, Northeast Agricultural University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Avian influenza (AI) and Newcastle disease (ND) are regarded as the leading viral infectious diseases affecting the global poultry industry. Vaccination is a successful therapeutic intervention to safeguard birds against both ND and AI infections. In this research, ND-AI bivalent vaccines were developed through the incorporation of HA and IRES-GMCSF gene fragments at varying locations of NDV rClone30 vectors. The two constructed vaccines were rClone30-HA-IRES-GMCSF(PM) and rClone30-HA(PM)-IRES-GMCSF(NP). Next, 27-day-old Luhua chickens (the maternal antibody level was reduced to 1.4 log2) were inoculated with the same dose of the vaccines, and humoral and cellular immune responses were assessed at multiple time points. Compared to the commercial vaccine, the levels of anti-NDV antibodies following the administration of the ND-AI vaccines were above the theoretical protection value of 4 log2. The levels of anti-AIV antibodies in the bivalent vaccine group were notably higher than those in the commercial vaccine group. Furthermore, the content of inflammatory factors and transcription levels were significantly increased in chickens administered ND-AI vaccines. The ND-AI vaccines induced stronger proliferative responses of B cells or CD3+, CD8+, and CD4 + T cells. Hematoxylin and eosin staining showed that the tissue damage induced by the two recombinant vaccines was similar to that of commercial vaccines. The outcomes of the study suggest that the two bivalent ND-AI vaccine candidates produced using the reverse genetics approach are both secure and effective. This approach not only enables the multiuse of one vaccine but also provides a new concept for the development of other vaccines against infectious viral diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Newcastle DiseaseViral VaccinesInfluenza in BirdsPoultry DiseasesInfluenza VaccinesAnimalsChickensNewcastle disease virusVaccines, CombinedVaccines, SyntheticAntibodies, Viral

Stichwörter der Autor:innen

Avian fluBivalent vaccineGM-CSFHumoral and cell-mediated immune responsesNewcastle disease

Substanzen

Viral VaccinesVaccines, CombinedVaccines, SyntheticAntibodies, ViralInfluenza Vaccines

Autor:innen und Institutionen

  • Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, China.
  • Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, China; Research Center of Genetic Engineering of Pharmaceuticals of Heilongjiang Province, Northeast Agricultural University, Ha…

Förderung

  • National Institutes of Health
  • National Natural Science Foundation of China
  • Northeast Agricultural University
  • Young Talents Project of Northeast Agricultural University

Zitieren

APA

Wu, Q., Wei, L., Du, X., Sun, W., Li, S., Guo, X., Jiang, M., Liu, J., Xue, Z., Li, H., Zhang, T., Wang, W., & Ren, G. (2023). Development and evaluation of Newcastle disease - avian influenza bivalent vector vaccines in commercial chickens. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110363

Vancouver

Wu Q, Wei L, Du X, Sun W, Li S, Guo X, et al. Development and evaluation of Newcastle disease - avian influenza bivalent vector vaccines in commercial chickens. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110363

BibTeX
@article{Wu2023,
  author = {Wu, Qing and Wei, Lan and Du, Xin and Sun, Wenying and Li, Shuang and Guo, Xiaochen and Jiang, Ming and Liu, Jinmiao and Xue, Zhiqiang and Li, Huijuan and Zhang, Tingting and Wang, Wei and Ren, Guiping},
  title = {Development and evaluation of Newcastle disease - avian influenza bivalent vector vaccines in commercial chickens},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110363}
}
Kostenlos starten →